A new generation of implantable electrodes
Therapeutic outcomes from clinical neural implants are limited by their mechanical properties. Their stiff and rigid designs present a mechanical mismatch compared to the soft and curved tissues they interface with, thereby constraining the physiological motion dynamics of the nervous system.
At Neurosoft Bioelectronics, we are addressing this issue by engineering elasticity in thin film materials to manufacture implantable electrodes that are much softer and flexible, and that can seamlessly interface with the nervous system.
Latest News
Neurosoft Bioelectronics is one of the 8 Prix Strategis semi-finalists!
We are proud to announce that Neurosoft Bioelectronics has been selected as one of the 8 semi-finalist startups competing for the Prix Strategis 2021. The Jury has selected our project out of 111 promising applicants. The next step will be a meeting with students from...
Welcome to Karsten Bagger – new Chief Business Officer (CBO)
We are happy to announce that Karsten Bagger has joined Neurosoft Bioelectronics as its Chief Business Officer (CBO).Karsten has a MSc in Finance, he previously worked at UBS as an investment strategist and over the past 6 years, he has mainly headed up medtech...
Venture Leader Nicolas Vachicouras shares his experience in creating Neurosoft Bioelectronics
In April our CEO and co-founder Nicolas Vachicouras was selected to represent Neurosoft Bioelectronics as part of the Swiss National Startup Team for Venture Leaders Life Sciences 2020. In November he will have the opportunity to travel to Boston, a major medical hub,...
Supported by
